Chromosomal damage induced by some ergot derivatives in vitro

Area of Science:

• Pharmacology
• Toxicology
• Genetics

Background:

• Ergot derivatives are compounds with various pharmacological effects.
• Chromosomal aberrations are indicators of potential mutagenicity.
• Human lymphocyte cultures are a standard model for genotoxicity testing.

Purpose of the Study:

• To evaluate the genotoxic potential of three ergot derivatives: dihydroergotoxine, ergotamine, and methysergide.
• To compare the chromosomal damage induced by these ergot derivatives with a known mutagen, caffeine.

Main Methods:

• Human lymphocytes were cultured in vitro.
• Cells were treated with varying concentrations (0.1, 0.25, 0.5 μg/ml) of dihydroergotoxine, ergotamine, and methysergide.
• Chromosomal aberration frequency was analyzed.
• Caffeine was used as a positive control.

Main Results:

• All three ergot derivatives significantly increased the frequency of chromosomal aberrations in a dose-dependent manner.
• The genotoxic effect of the ergot derivatives was less pronounced compared to caffeine at the tested concentrations.
• Caffeine, used as a positive control, demonstrated significant mutagenic activity.

Conclusions:

• Dihydroergotoxine, ergotamine, and methysergide possess clastogenic activity in human lymphocytes.
• The in vitro genotoxicity of these ergot derivatives is considerably lower than that of caffeine.
• Further investigation into the long-term effects and mechanisms of ergot derivative genotoxicity may be warranted.